The controversial Dengvaxia dengue vaccine will no longer have the prospect of being sold in the Philippines as the Food and Drug Administration (FDA) permanently revoked its certificate of product registration (CPR) on Tuesday, February 19.
Story: https://www.rappler.com/nation/223848-fda-permanently-revokes-certificate-product-registration-dengvaxia
